Bovine Diagnostics Market Size Report & Share Analysis 2030

Bovine Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products), Disease Type [Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and Other Disease Types], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography

Publication Month : Sep 2023

  • Report Code : TIPRE00030034
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 152
Inquire Before Buy



[Research Report] The bovine diagnostics market was valued at US$ 1,155.59 million in 2022 and is expected to reach US$ 2,011.15 million by 2030. It is estimated to register a CAGR of 7.2% during 2022–2030.

Market Insights and Analyst View:

Developments in the global healthcare sector such as growing digitalization and automation define the growth of the bovine diagnostics market. Technological advancements and automation have led to smart laboratories and imaging services. In addition, the awareness of animal health and availability of veterinary diagnostics have led to the overall growth of the veterinary diagnostics market. Moreover, there is a growing demand for bovine diagnostics from cattle farmers to enhance the health of their herds to obtain the best-quality meat, dairy products, and other food and commercial products.

The growing adoption of artificial intelligence technologies in veterinary diagnostics is likely to substantially benefit the progress of the bovine diagnostics market. Also, the increasing use of liquid biopsies and point-of-care products is expected to serve good growth opportunities in the bovine diagnostics market in the coming years. Ongoing and anticipated mergers, collaborations, and strategic decisions by key players would further drive the progress of the bovine diagnostics market in the future.

Growth Drivers and Challenges:

Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion. In the US alone, the cost of subclinical mastitis is expected to exceed to US$ 1 billion annually. Therefore, continuous monitoring and risk analysis are required to prevent huge economic losses. As per the National Bureau of Statistics of China 2022, China has cattle counts of 102.16 million while milk production is 39.32 million tons. The published data also stated that the prevalence of bovine mastitis is ~60–70%, and clinical mastitis accounts for ~21–23% mortality in cattle. Further, the data revealed that dairy mastitis costs ~US$ 15–45 billion to China every year.

According to the study “Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis,” published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011–2019. In India, the prevalence of SCM and CM were 45% and 18%, respectively, during 2011–2019. The study also stated that North America and Europe had a higher prevalence of SCM, while countries such as the UK and Uganda had a higher prevalence of CM. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.

The lack of skilled professionals in veterinary research hinders the bovine diagnostics market growth. Factors such as the lack of suitable remuneration guarantees, the risk of animal-borne disorders, and concerns regarding ethics and animal welfare make veterinary research a less attractive field for workforces. Owing to technological advancements and the changing work nature, the requirement for skilled veterinary professionals capable of operating sophisticated tools and devices has increased. Meanwhile, businesses in veterinary medicine seek candidates with advanced management skills to propel larger, more complex businesses. According to the US National Research Council Committee, veterinary research institutes and companies face challenges in maintaining the economic sustainability of veterinary practices and education, and transforming their veterinary services to meet changing societal needs.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Bovine Diagnostics Market: Strategic Insights

Market Size Value inUS$ 1,155.59 million in 2022
Market Size Value byUS$ 2,011.15 million by 2030
Growth rateCAGR of 7.2% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The bovine diagnostics market is segmented on the basis of product, disease type, and end user. Based on product, the market is classified into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The market growth of the immunoassay kits segment is attributed to the use of kits for various clinical diagnoses, innovative offerings by key players, and technological advancements in test kits.

Based on the disease type, the bovine diagnosticsmarket is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The growth of the market for disease type is attributed to the occurrence of various bovine diseases and the availability of key players offering diagnostics kits for these diseases.

Based on end user, the bovine diagnostics market is classified into veterinary hospitals, veterinary clinics, and others. The growth of the market by end user is attributed to support from governments and growing research on bovine diseases. Based on geography, the bovine diagnostics market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on product, the bovine diagnostics market is segmented into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assay, and others. The immunoassay kits segment is estimated to be the largest and fastest-growing segment in the market during 2022–2030. An immunoassay kit uses immunological proteins and antibodies to detect molecules of interest. These molecules can be any antigen such as bacteria, viruses, hormones, or antibodies. Antigens are molecules against which the body produces an immune response. Laboratory bench-top kits, known as enzyme-linked immunosorbent assays (ELISA) kits, are used in laboratories, clinical settings, and veterinary industry. Clinical settings and core facilities typically use larger instrumentation for assays, such as latex turbidity immunoassays (LTIA) and chemiluminescent immunoassays (CLIA). The immunoassay kits are used for various clinical diagnosis such as haptoglobin in biological samples of cattle, bovine lumpy skin disease (LSDV), quantitative detection of bovine IgM, and foot and mouth disease virus in cattle.

Many companies offer a wide range of immunoassay kits for diagnosis of bovine diseases. Innovative Research offers the Bovine IgM ELISA Kit, which is a highly sensitive two-site ELISA for measuring IgM in bovine biological samples for up to 96 tests. Thus, application of immunoassay kits for various clinical diagnosis and offering by key players promote the bovine diagnostics market growth for the immunoassay kits segment.

Bovine Diagnostics Market, by Product – 2022 and 2030

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Based on disease type, the bovine diagnostics market is categorized into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. The bovine mastitis segment held the largest market share in 2022 and is also anticipated to register the highest CAGR during 2022–2030.

On the basis of end user, the bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment held the largest market share in 2022, and the same segment is anticipated to register the highest CAGR during 2022–2030.

Regional Analysis:

Based on geography, the bovine diagnostics market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the market, and Asia Pacific is expected to record the fastest CAGR during 2022–2030. The factors that are leading the growth of market in North America are the increasing number of product launches and government initiatives, and ongoing developments in diagnostics technologies. The US holds the largest share of the bovine diagnostics market in North America. The bovine diagnostics market growth in the US is attributed to the rising government efforts to control zoonotic diseases, mastitis, and tuberculosis. Continuous developments in veterinary diagnostics result in frequent bovine diagnostics product launches. In October 2022, the Kansas State Veterinary Diagnostic Laboratory of the Kansas State University College of Veterinary Medicine developed a test to detect two major blood-borne diseases in cattle. Researchers at Kansas State Veterinary Diagnostic Laboratory developed a polymerase chain reaction (PCR) technique to detect endemic anaplasmosis and emerging theileriosis. The test will allow veterinarians and cattle farmers to diagnose the herds with disease-causing microorganisms, and help them effectively prevent and manage the diseases. In June 2023, Neogen Corporation launched Igenity BeefXDairy. It is a novel genomic test for beef-on-dairy calves. Igenity BeefXDairy provides insights about some key traits, including carcass quality, average daily gain, and the Igenity Terminal Index. These insights help calf producers to market their cattle to potential buyers.

The increasing incidences of bovine tuberculosis (bTB) and bovine viral diarrhea in cattle, rising demand for milk and meat products, and surging government initiatives for bovine diagnostics benefit the bovine diagnostics market growth in Asia Pacific.

Industry Developments and Future Opportunities:

Various initiatives by key players operating in the bovine diagnostics market are listed below:

  1. In July 2023, PBD Biotech, a developer of a ground-breaking phage-based diagnostic tool for laboratory tuberculosis testing, secured a US patent for its Actiphage TB diagnostic kit. Grant of this US patent is related to the detection of Mycobacteria using bacteriophages, specifically to the diagnostic kit, providing intellectual property rights to the company for its Actiphage technology.
  2. In June 2023, Ringbio, a Chinese biotechnology company, participated in the Dairy, Livestock, and Poultry Technology Exhibition Africa 2023 (DLP Expo Africa 2023), held at Kenyatta International Convention Centre, Kenya, from June 15th to 17th. Ringbio displayed its products and solutions for food safety, animal disease, and clinical testing at the expo. A few of the featured products included Bovine Pregnancy Rapid Test Kit & Solutions, Cattle Tests, and Goat/sheep Tests.
  3. In March 2021, PBD Biotech secured US$ 3.16 million of investment to take Actiphage through to the World Organisation for Animal Health (OIE) validation. Actiphage is a rapid, accurate test for bovine tuberculosis diagnosis, which would enable farmers to effectively remove the devastating disease from their herds. Its full validation would further enable international adoption of this novel, patented diagnostic tool for mycobacterial diseases, including human tuberculosis and Johne’s disease.

COVID-19 Impact:

The bovine diagnostics market players experienced a steady increase in demand before the onset of the COVID-19 pandemic. These diagnostics mainly include ELISA, PCR, and hemagglutination inhibition (HI) assays. Bovine diseases can be controlled by performing diagnostic tests to screen infected cattle for culling or segregation while keeping most ELISA-positive cattle posing a low risk of infections to other animals in the herd.

The bovine diagnostics market declined notably after the onset of the COVID-19 pandemic amid the lockdown measures implemented in several nations, which led to the shutdown of veterinary clinics. This scenario made it difficult for cattle farmers to obtain proper veterinary diagnosis and treatment because of the cancellation and reduction of veterinarian appointments. Despite the health crisis across the world, various initiatives were taken by governments of different countries and companies in the veterinary therapeutics industry to continue their eradication programs. For instance, according to the Michigan Department of Agriculture and Rural Development (MDARD), activities under the Bovine Tuberculosis Eradication Program in the US, including testing cattle for TB, continued while precautions were taken to prevent COVID-19 spread.

Competitive Landscape and Key Companies:

A few prominent players operating in the bovine diagnostics market are Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product, Disease Type, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions

Who are the key players in the bovine diagnostics market?

Companies operating in the market are Idexx Laboratories Inc, PBD Biotech Ltd, Thermo Fisher Scientific Inc, Innovative Diagnostics SAS, Neogen Corp, Enfer Labs, bioMerieux SA, Ring Biotechnology Co Ltd, Bionote Inc, and Shenzhen Bioeasy Biotechnology Co Ltd.

What is the regional market scenario of the bovine diagnostics market?

Global bovine diagnostics market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the bovine diagnostics market during 2022–2030. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving and restraining factors for the bovine diagnostics market across the globe?

The factors driving the market include the high prevalence and economic impact of bovine mastitis and increasing number of product launches. However, the lack of skilled professionals in veterinary research hinders the market growth.

What is the segmentation for the bovine diagnostics market?

The bovine diagnostics market is segmented into product, disease type, and end user. By product, the bovine diagnostics market is bifurcated into immunoassay kits, PCR kits, hemagglutination inhibition (HI) assay, and others. Based on disease type, the market is categorized into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and others. And on the basis of end user, the bovine diagnostics market is divided into veterinary hospitals, veterinary clinics, and others.

The List of Companies - Bovine Diagnostics Market

  1. Idexx Laboratories Inc.
  2. PBD Biotech Ltd
  3. Thermo Fisher Scientific Inc.
  4. Innovative Diagnostics SAS
  5. Neogen Corp
  6. Enfer Labs
  7. bioMerieux SA
  8. Ring Biotechnology Co Ltd.
  9. Bionote Inc
  10. Shenzhen Bioeasy Biotechnology Co Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Bovine Diagnostics Market